APOB and type 2 diabetes mellitus: For individuals aged 40 years and older with T2DM, statin therapy is recommended regardless of baseline LDL-C levels, owing to its capacity to lower apolipoprotein B (apoB) levels and reduce the number of circulating atherogenic particles.